WilliamLaurenceDahutMD

Clinical Trials

• Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer Start of enrollment: 2000 Mar 01

  Completed

  Phase 3

• 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors Start of enrollment: 2001 Sep 01

  Completed

  Phase 1

• CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy Start of enrollment: 2002 Apr 01

  Completed

  Phase 1

• Ketoconazole Plus Docetaxel to Treat Prostate Cancer Start of enrollment: 2002 Mar 19

  Completed

  Phase 1

• Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer Start of enrollment: 2005 Apr 19

  Completed

  Phase 2

• A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer Start of enrollment: 2004 Sep 01

  Completed

  Phase 2

• AZD2171 to Treat Prostate Cancer Start of enrollment: 2006 Oct 16

  Completed

  Phase 2

• Satraplatin and Prednisone to Treat Prostate Cancer Start of enrollment: 2008 Feb 19

  Completed

  Phase 2

• Data Collection, Clinical Care and Interventions in CCR, NCI Start of enrollment: 2004 Jun 10

  Enrolling by invitation

• A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer Start of enrollment: 2009 Jul 16

  Completed

  Phase 2

• A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) Start of enrollment: 2010 Feb 23

  Completed

  Phase 1, Phase 2

• AMG 386 and Abiraterone for Advanced Prostate Cancer Start of enrollment: 2012 Feb 08

  Completed

  Phase 2

• Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma Start of enrollment: 2012 Mar 01

  Withdrawn

  Phase 1

• Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer Start of enrollment: 2012 Sep 07

  Completed

  Phase 1, Phase 2

• Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders Start of enrollment: 2015 Jun 01
• Join now to see all